Page last updated: 2024-12-05

allyl acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Allyl acetate is an organic compound with the formula CH3COOCH2CH=CH2. It is a colorless liquid with a fruity odor. It is used as a flavoring agent and as an intermediate in the synthesis of other chemicals. Allyl acetate can be synthesized by the reaction of allyl alcohol with acetic anhydride in the presence of a catalyst. It has been shown to be a potential insecticide and antimicrobial agent. Allyl acetate is a component of some essential oils and is also used in the production of plastics and resins. It is an important compound in the study of organic chemistry and its reactions. Due to its reactivity and versatility, it is a valuable intermediate in various organic syntheses, including the production of pharmaceuticals, pesticides, and polymers. Research on allyl acetate focuses on understanding its various chemical and biological properties, exploring its potential applications, and developing sustainable and efficient synthesis methods.'

allyl acetate: potential fumigant for treating stored grains [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11584
CHEMBL ID1890774
SCHEMBL ID64376
MeSH IDM0482686

Synonyms (62)

Synonym
acetic acid, 2-propen-1-yl ester
unii-e4u5e5990i
4-02-00-00180 (beilstein handbook reference)
e4u5e5990i ,
allyl acetate [un2333] [flammable liquid]
AKOS015841096
591-87-7
1-propen-2-ol acetate
acetic acid, 2-propenyl ester
acetic acid, allyl ester
2-propenyl ethanoate
wln: 1vo2u1
allyl acetate
3-acetoxypropene
nsc-7612
2-propenyl acetate
nsc7612
inchi=1/c5h8o2/c1-3-4-7-5(2)6/h3h,1,4h2,2h
alloac
NCGC00091489-01
brn 1742050
hsdb 2697
ai3-22625
einecs 209-734-8
2-propenyl methanoate
nsc 7612
3-acetoxy-1-propene
un2333
GHL.PD_MITSCHER_LEG0.414
allyl acetate, 99%
A0020
acetic acid allyl ester
prop-2-enyl acetate
FT-0658812
acetic acid prop-2-enyl ester
prop-2-enyl ethanoate
A801825
A832199
NCGC00091489-02
tox21_200335
cas-591-87-7
dtxcid904437
NCGC00257889-01
dtxsid9024437 ,
STL280512
prop-2-en-1-yl acetate
FT-0627460
acetic acid, allyl ester [hsdb]
allyl acetate [mi]
SCHEMBL64376
CHEMBL1890774
un 2333
2-propenyl ester of acetic acid
ch2=c(ch3)oc(=o)ch3
J-519553
2-propen-1-ol acetate
mfcd00008721
allyl acetate, purum, >=98.0% (gc)
Q4488673
AMY22115
AT33085
29467-34-3

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" When dosed at quantities limited by toxicity, allyl acetate and allyl alcohol produce higher levels of urinary mercapturic acids than the minimally toxic dose of acrolein."( A comparative 90-day toxicity study of allyl acetate, allyl alcohol and acrolein.
Auerbach, SS; Irwin, RD; Mahler, J; Travlos, GS, 2008
)
0.87

Dosage Studied

ExcerptRelevanceReference
" Rats (10/group) were dosed with 0-100mg/kg allyl acetate, 0-25mg/kg allyl alcohol, or 0-10mg/kg acrolein."( A comparative 90-day toxicity study of allyl acetate, allyl alcohol and acrolein.
Auerbach, SS; Irwin, RD; Mahler, J; Travlos, GS, 2008
)
0.88
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency26.91770.000221.22318,912.5098AID1259243
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency53.70790.001022.650876.6163AID1224838
progesterone receptorHomo sapiens (human)Potency1.90560.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency75.86440.003041.611522,387.1992AID1159553
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency61.03190.001530.607315,848.9004AID1224841; AID1224848; AID1224849
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.00250.010039.53711,122.0200AID588545
Nuclear receptor ROR-gammaHomo sapiens (human)Potency0.09440.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (42)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (23.81)29.6817
2010's31 (73.81)24.3611
2020's1 (2.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.70 (24.57)
Research Supply Index3.76 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index63.25 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other42 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]